PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
HRMY vs. PRTH
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between HRMY and PRTH is 0.15, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

HRMY vs. PRTH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Harmony Biosciences Holdings, Inc. (HRMY) and Priority Technology Holdings, Inc. (PRTH). The values are adjusted to include any dividend payments, if applicable.

0.00%50.00%100.00%150.00%SeptemberOctoberNovemberDecember2025February
6.23%
144.83%
HRMY
PRTH

Key characteristics

Sharpe Ratio

HRMY:

0.34

PRTH:

3.25

Sortino Ratio

HRMY:

0.79

PRTH:

3.22

Omega Ratio

HRMY:

1.10

PRTH:

1.44

Calmar Ratio

HRMY:

0.29

PRTH:

3.60

Martin Ratio

HRMY:

1.25

PRTH:

21.03

Ulcer Index

HRMY:

12.31%

PRTH:

12.38%

Daily Std Dev

HRMY:

44.86%

PRTH:

80.30%

Max Drawdown

HRMY:

-68.48%

PRTH:

-88.12%

Current Drawdown

HRMY:

-35.82%

PRTH:

-1.79%

Fundamentals

Market Cap

HRMY:

$2.23B

PRTH:

$987.45M

EPS

HRMY:

$2.11

PRTH:

-$0.42

Total Revenue (TTM)

HRMY:

$513.47M

PRTH:

$652.64M

Gross Profit (TTM)

HRMY:

$399.14M

PRTH:

$169.38M

EBITDA (TTM)

HRMY:

$158.05M

PRTH:

$143.75M

Returns By Period

In the year-to-date period, HRMY achieves a 13.60% return, which is significantly higher than PRTH's 2.72% return.


HRMY

YTD

13.60%

1M

0.10%

6M

9.19%

1Y

15.62%

5Y*

N/A

10Y*

N/A

PRTH

YTD

2.72%

1M

35.62%

6M

151.98%

1Y

258.16%

5Y*

36.42%

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

HRMY vs. PRTH — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HRMY
The Risk-Adjusted Performance Rank of HRMY is 5656
Overall Rank
The Sharpe Ratio Rank of HRMY is 5757
Sharpe Ratio Rank
The Sortino Ratio Rank of HRMY is 5252
Sortino Ratio Rank
The Omega Ratio Rank of HRMY is 5252
Omega Ratio Rank
The Calmar Ratio Rank of HRMY is 5858
Calmar Ratio Rank
The Martin Ratio Rank of HRMY is 5959
Martin Ratio Rank

PRTH
The Risk-Adjusted Performance Rank of PRTH is 9595
Overall Rank
The Sharpe Ratio Rank of PRTH is 9898
Sharpe Ratio Rank
The Sortino Ratio Rank of PRTH is 9292
Sortino Ratio Rank
The Omega Ratio Rank of PRTH is 9292
Omega Ratio Rank
The Calmar Ratio Rank of PRTH is 9696
Calmar Ratio Rank
The Martin Ratio Rank of PRTH is 9797
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

HRMY vs. PRTH - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Harmony Biosciences Holdings, Inc. (HRMY) and Priority Technology Holdings, Inc. (PRTH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for HRMY, currently valued at 0.34, compared to the broader market-2.000.002.004.000.343.25
The chart of Sortino ratio for HRMY, currently valued at 0.79, compared to the broader market-6.00-4.00-2.000.002.004.006.000.793.22
The chart of Omega ratio for HRMY, currently valued at 1.10, compared to the broader market0.501.001.502.001.101.44
The chart of Calmar ratio for HRMY, currently valued at 0.29, compared to the broader market0.002.004.006.000.293.92
The chart of Martin ratio for HRMY, currently valued at 1.25, compared to the broader market0.0010.0020.0030.001.2521.03
HRMY
PRTH

The current HRMY Sharpe Ratio is 0.34, which is lower than the PRTH Sharpe Ratio of 3.25. The chart below compares the historical Sharpe Ratios of HRMY and PRTH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.00SeptemberOctoberNovemberDecember2025February
0.34
3.25
HRMY
PRTH

Dividends

HRMY vs. PRTH - Dividend Comparison

Neither HRMY nor PRTH has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

HRMY vs. PRTH - Drawdown Comparison

The maximum HRMY drawdown since its inception was -68.48%, smaller than the maximum PRTH drawdown of -88.12%. Use the drawdown chart below to compare losses from any high point for HRMY and PRTH. For additional features, visit the drawdowns tool.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%SeptemberOctoberNovemberDecember2025February
-35.82%
-1.79%
HRMY
PRTH

Volatility

HRMY vs. PRTH - Volatility Comparison

The current volatility for Harmony Biosciences Holdings, Inc. (HRMY) is 8.91%, while Priority Technology Holdings, Inc. (PRTH) has a volatility of 12.46%. This indicates that HRMY experiences smaller price fluctuations and is considered to be less risky than PRTH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%30.00%35.00%SeptemberOctoberNovemberDecember2025February
8.91%
12.46%
HRMY
PRTH

Financials

HRMY vs. PRTH - Financials Comparison

This section allows you to compare key financial metrics between Harmony Biosciences Holdings, Inc. and Priority Technology Holdings, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab